List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 880 studies with search of:   "Gemcitabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: PF-3512676;   Drug: Cisplatin;   Drug: Gemcitabine + Cisplatin
2 Recruiting Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Gemcitabine
3 Completed Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Gemcitabine
4 Recruiting Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Gemcitabine;   Drug: Erlotinib;   Drug: Oxaliplatin
5 Not yet recruiting Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine;   Drug: LAG-3 and Gemcitabine;   Drug: LAG-3 and gemcitabine;   Drug: LAG-3 and gemcitabine;   Drug: LAG-3 and gemcitabine
6 Recruiting A Randomized Study of Amplimexon With Gemcitabine in Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: imexon + gemcitabine;   Drug: imexon placebo + gemcitabine
7 Completed EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma;   Metastasis;   Pancreas Neoplasms
Interventions: Drug: Gemcitabine alone;   Drug: EndoTAG-1 and Gemcitabine;   Drug: EndoTAG-1 and Gemcitabine;   Drug: EndoTAG-1 and Gemcitabine
8 Suspended A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: placebo + gemcitabine + erlotinib;   Drug: Placebo + gemcitabine;   Drug: calcitriol + gemcitabine;   Drug: calcitriol + gemcitabine + erlotinib
9 Recruiting GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine + S-1;   Drug: gemcitabine
10 Recruiting Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: AG-013736;   Drug: Gemcitabine;   Drug: Gemcitabine;   Drug: placebo
11 Recruiting Open-Label Study of CS1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: CS-1008 (humanized anti-DR5 antibody) plus gemcitabine;   Drug: CS-1008 + gemcitabine,
12 Recruiting Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine plus TS-1;   Drug: TS-1;   Drug: Gemcitabine
13 Recruiting First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine + Sunitinib;   Drug: Gemcitabine
14 Recruiting Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Condition: Bladder Cancer
Interventions: Drug: Gemcitabine, Cisplatin;   Drug: Gemcitabine, Cisplatin and Cetuximab
15 Recruiting A Phase I/Expansion Study of Dasatinib
Conditions: Refractory Solid Tumors;   Pancreatic Adenocarcinoma
Interventions: Drug: gemcitabine;   Drug: dasatinib;   Drug: gemcitabine;   Drug: dasatinib
16 Completed AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine;   Drug: AG-013736 plus gemcitabine
17 Recruiting Pemetrexed Plus Gemcitabine in Renal Cell Cancer
Condition: Renal Cell Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Gemcitabine
18 Recruiting Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Conditions: Solid Tumor;   Urethral Cancer
Interventions: Drug: Bortezomib;   Drug: Gemcitabine;   Drug: Doxorubicin
19 Recruiting A Phase III Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)
Conditions: NSCLC;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006) plus gemcitabine and cisplatin;   Drug: placebo plus gemcitabine and cisplatin
20 Completed Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy
Condition: Locally Advanced Pancreatic Cancer
Interventions: Drug: gemcitabine;   Other: 125I brachytherapy PLUS gemcitabine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services